2024 |
Takeda Pharmaceutical Co - ADR
|
Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.A., Inc. |
1.7 B |
-1.2 % |
2023 |
Takeda Pharmaceutical Co - ADR
|
Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.A., Inc. |
1.7 B |
-0.5 % |
2022 |
Takeda Pharmaceutical Co - ADR
|
- |
1.7 B |
-24.5 % |
2022 |
Takeda Pharmaceutical Co - ADR
|
Director, President and Chief Executive Officer |
1.7 B |
-24.5 % |
2021 |
Takeda Pharmaceutical Co - ADR
|
Director, President and Chief Executive Officer |
2.3 B |
10.6 % |
2021 |
Takeda Pharmaceutical Co - ADR
|
- |
2.3 B |
10.6 % |
2021 |
Takeda Pharmaceutical Co - ADR
|
Director, President and Chief Executive Officer |
2.3 B |
10.6 % |
2020 |
Takeda Pharmaceutical Co - ADR
|
- |
2.1 B |
- |
2020 |
Takeda Pharmaceutical Co - ADR
|
- |
2.1 B |
- |
2020 |
Takeda Pharmaceutical Co - ADR
|
Representative Director, President and Chief Executive Officer |
2.1 B |
- |
2019 |
Takeda Pharmaceutical Co - ADR
|
Representative Director, President and Chief Executive Officer |
- |
- |